• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

tax reform

  1. Celgene's 4th quarter 2017 sales and profit beat estimates

    http://alph.st/ba1df6ff Higher sales of Revlimid and Otezla help Celgene to report better than expected sales figure. Will the two (Impact and Juno) multi-billion dollar acquisitions help the struggling Celgene in 2018 and beyond?
  2. Tax Reform: Will Merck Share the Wealth?

    Now that the large corporate tax reduction has passed Congress, what actions will Merck management take? Will there be a one-time goodwill donation of medication? Will they provide a one-time holiday bonus to their employees (a long ago past practice at Merck). Will the cash held overseas come...